Thwarting Individual Accountability:
What Does Reinvigorated Enforcement Mean for Responsible Corporate Officers and Counsel?

American Conference Institute’s 12th National Summit on Reducing Legal Risks in the Sales and Marketing of Medical Devices

04/23/2012 - 04/24/2012

Securities Litigation

Doubletree Hotel Chicago
300 E. Ohio Street
Chicago, IL 60611

Speaking Engagement

Topics Include:

  • Learning how to cope with corporate life under a microscope in an era of heightened governmental scrutiny
    - acts and omissions that may lead to FDA, DOJ, or SEC investigations
    - reducing brazen forms of behavior
  • Representing yourself accurately and producing documents to avoid false claims or obstruction allegations
  • Fostering proper and ethical behavior through demonstrated compliance with voluntary industry codes such as AdvaMed
    - utilizing codes as a benchmark for ethics
  • Understanding when to “toe the line” and when to err on the side of caution in your sales and marketing practices
  • Defining who within a company can be “responsible” under FDA standards
    - collateral consequences of a Park conviction
  • Working through available defenses to a Park charge
  • Analyzing gate-keeper enforcement against in-house and outside counsel
  • Determining the value and limitations of seeking outside legal guidance to advise on marketing and other operational matters, as well as investigative issues

Email Disclaimer

Unsolicited e-mails and information sent to Morrison & Foerster will not be considered confidential, may be disclosed to others pursuant to our Privacy Policy, may not receive a response, and do not create an attorney-client relationship with Morrison & Foerster. If you are not already a client of Morrison & Foerster, do not include any confidential information in this message. Also, please note that our attorneys do not seek to practice law in any jurisdiction in which they are not properly authorized to do so.

©1996-2019 Morrison & Foerster LLP. All rights reserved.